Published in Psychiatry Res on October 01, 1993
Magnetoencephalography as a putative biomarker for Alzheimer's disease. Int J Alzheimers Dis (2011) 0.94
Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring. Int J Alzheimers Dis (2011) 0.91
The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study. J Neurooncol (2008) 0.88
EEG-microstates in mild memory impairment and Alzheimer's disease: possible association with disturbed information processing. J Neural Transm (Vienna) (1997) 0.87
Mapping cognitive function. Neuroimaging Clin N Am (2007) 0.86
The implicit function as squashing time model: a novel parallel nonlinear EEG analysis technique distinguishing mild cognitive impairment and Alzheimer's disease subjects with high degree of accuracy. Comput Intell Neurosci (2007) 0.86
Is sleep essential for neural plasticity in humans, and how does it affect motor and cognitive recovery? Neural Plast (2013) 0.82
Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms. Front Neurosci (2016) 0.80
Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states. Neural Plast (2015) 0.79
Quantitative electroencephalography in Alzheimer's disease: comparison with a control group, population norms and mental status. J Psychiatry Neurosci (2001) 0.78
Direction of Information Flow in Alzheimer's Disease and MCI Patients. Int J Alzheimers Dis (2011) 0.77
Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2014) 0.77
Elman neural network for the early identification of cognitive impairment in Alzheimer's disease. Funct Neurol (2014) 0.76
A novel method of early diagnosis of Alzheimer's disease based on EEG signals. ScientificWorldJournal (2015) 0.76
Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals. Neuroimage Clin (2016) 0.75
Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks. Front Neurosci (2017) 0.75
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Isolation and nucleotide sequence of the methanol dehydrogenase structural gene from Paracoccus denitrificans. J Bacteriol (1987) 1.96
Arthritis associated with apatite crystals. Ann Intern Med (1977) 1.92
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand (1999) 1.72
The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry (1993) 1.63
Psychosocial work factors and dementia. Occup Environ Med (2004) 1.62
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Neurology (2007) 1.45
The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol (1998) 1.44
IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res (1992) 1.44
Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry (2011) 1.40
[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?]. Dtsch Med Wochenschr (2005) 1.39
[Mild cognitive impairment with predictors of rapid decline]. Dtsch Med Wochenschr (2008) 1.39
Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980. Vital Health Stat 1 (1981) 1.36
Plan and operation of the HANES I augmentation survey of adults 25-74 years United States, 1974-1975. Vital Health Stat 1 (1978) 1.29
Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand (2007) 1.22
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res (1998) 1.21
Effects of arousing emotional scenes on the distribution of visuospatial attention: changes with aging and early subcortical vascular dementia. J Neurol Sci (2004) 1.19
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17
The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia. Eur J Neurol (2005) 1.15
Can estradiol modulate schizophrenic symptomatology? Schizophr Bull (1994) 1.15
Isolation and characterization of Paracoccus denitrificans mutants with defects in the metabolism of one-carbon compounds. J Bacteriol (1985) 1.14
ABC Schizophrenia study: an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol (2013) 1.13
Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull (1998) 1.12
Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int Psychogeriatr (1997) 1.11
Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage (2002) 1.11
Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol (2000) 1.11
First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci (1992) 1.09
Signal processing and calibration procedures for in situ diode-laser absorption spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc (2004) 1.08
Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun (2009) 1.08
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett (1999) 1.08
How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med (1989) 1.06
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology (2009) 1.05
Synovitis in secondary syphilis. Clinical, light, and electron microscopic studies. Arthritis Rheum (1979) 1.05
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med (1993) 1.04
Exposure to environmental tobacco smoke and risk factors for heart disease among never smokers in the Third National Health and Nutrition Examination Survey. Am J Epidemiol (1998) 1.03
Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging Ment Health (2009) 1.03
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl (2007) 1.02
Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology (Berl) (2000) 1.02
Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res (1992) 0.98
[Schizophrenia and age]. Nervenarzt (1991) 0.98
C-terminal domains of general regulatory factors Abf1p and Rap1p in Saccharomyces cerevisiae display functional similarity. Mol Microbiol (1996) 0.97
Visual pattern evoked responses and blink reflexes in assessment of MS diagnosis. A clinical study of 135 multiple sclerosis/pathol. J Neurol (1976) 0.97
Stage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type. Psychiatry Res (1989) 0.96
Dual actions of adenosine on rat peritoneal mast cells. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.96
The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry Suppl (1994) 0.95
Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem (1995) 0.94
IFCN recommended standards for long-latency auditory event-related potentials. Report of an IFCN committee. International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol (1994) 0.94
[The effect of psychosocial factors on risk of dementia]. Fortschr Neurol Psychiatr (2002) 0.93
When and how does schizophrenia produce social deficits? Eur Arch Psychiatry Clin Neurosci (1995) 0.92
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. J Neurol Neurosurg Psychiatry (2009) 0.92
P300 asymmetries in schizophrenia revisited with reference-independent methods. Psychiatry Res (1994) 0.92
Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability. Soc Psychiatry Psychiatr Epidemiol (1992) 0.92
Epidural analgesia and perioperative kidney function after major liver resection. Br J Surg (2015) 0.91
Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J Neural Transm Suppl (2007) 0.91
Event-related potentials and psychopharmacology. Cholinergic modulation of P300. Pharmacopsychiatry (1994) 0.90
Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease. Psychiatry Res (1999) 0.90
Physiological regulation of Paracoccus denitrificans methanol dehydrogenase synthesis and activity. J Bacteriol (1988) 0.90
Basic data on arthritis knee, hip, and sacroiliac joints in adults ages 25-74 years. Vital Health Stat 11 (1979) 0.90
Kluyveromyces contains a functional ABF1-homologue. Nucleic Acids Res (1992) 0.90
Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. Am J Pathol (1996) 0.89
EEG-correlates of facial affect recognition and categorisation of blurred faces in schizophrenic patients and healthy volunteers. Schizophr Res (2001) 0.89
The experimental combination of rTMS and fMRI reveals the functional relevance of parietal cortex for visuospatial functions. Brain Res Cogn Brain Res (2002) 0.88
Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia. Psychiatry Res (1991) 0.88
Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. Eur Arch Psychiatry Clin Neurosci (1992) 0.88
EEG-microstates in mild memory impairment and Alzheimer's disease: possible association with disturbed information processing. J Neural Transm (Vienna) (1997) 0.87
Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine. Psychopharmacology (Berl) (2001) 0.87
Enhanced ROS-generation in lymphocytes from Alzheimer's patients. Pharmacopsychiatry (2005) 0.87
Synergistic effects of calcium-mobilizing agents and adenosine on histamine release from rat peritoneal mast cells. Br J Pharmacol (1989) 0.87
Computerized self-assessment in psychiatric in-patients: acceptability, feasibility and influence of computer attitude. Acta Psychiatr Scand (1998) 0.86
Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study. Eur Arch Psychiatry Neurol Sci (1986) 0.85
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging (2012) 0.85
Progression of Alzheimer disease in Europe: data from the European ICTUS study. Curr Alzheimer Res (2012) 0.85
Hypocomplementemic urticarial vasculitis with glomerulonephritis and pseudotumor cerebri. Arthritis Rheum (1979) 0.85
Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord (1995) 0.84
Perceiving individuals and groups: expectancies, dispositional inferences, and causal attributions. J Pers Soc Psychol (1999) 0.84
Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J Neural Transm (Vienna) (2004) 0.84
A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (1997) 0.83
Analysis of the THR4 region on chromosome III of the yeast Saccharomyces cerevisiae. Yeast (1990) 0.83
Blood pressure levels of persons 6-74 years. United States, 1971-1974. Vital Health Stat 11 (1977) 0.83
Electrophysiological correlates of emotional and structural face processing in humans. Neurosci Lett (2000) 0.83
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm Suppl (1995) 0.83
[Creative therapy options for patients with dementia--a systematic review]. Fortschr Neurol Psychiatr (2006) 0.83
Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur Arch Psychiatry Clin Neurosci (1991) 0.83